GSK’s Blenrep (belantamab mafodotin) has been recommended by the National Institute for Health and Care Excellence (NICE) as ...

England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological ...

The National Institute for Health and Care Excellence (NICE) has issued a draft guidance recommending GSK’s Blenrep (belantamab mafodotin) in combination with bortezomib and dexamethasone (BVd) for ...

The targeted therapy can stop myeloma from progressing by nearly three times as long as existing treatments, studies suggest. | ITV National News ...

A “TROJAN HORSE” therapy that sneaks toxic drugs inside and kills cancer cells is being rolled out on the NHS in England in a ...

England becomes the first country to offer the world’s pioneering 'Trojan horse' blood cancer drug, through NHS, promising ...

New therapy nearly triples disease-free survival time for some patients with bone marrow cancer in world-first recommendation ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...